LE

Lori Englebert

EVP, Commercial & Business Development at Axsome Therapeutics

Ms. Englebert has served as the Executive Vice President, Commercial and Business Development since March 2022 and has been a member of the Axsome team since September 2019.

Prior to joining Axsome, Ms. Englebert spent 11 years at Amgen where she held leadership positions in commercial, corporate strategy, and business development, including responsibility for multiple commercial product launches. Prior to Amgen, Ms. Englebert started her career at Novartis where she held positions of increasing responsibility in corporate strategy. She earned her BA and MBA from Wake Forest University.

Timeline

  • EVP, Commercial & Business Development

    Current role

  • SVP, Commercial & Business Development

View in org chart